ERT expands corporate presence in Japan

Wednesday, January 16, 2013 09:26 AM

ERT, a global technology-driven provider of health outcomes research services, has completed registration for Kabushiki Kaisha (KK) in Japan and has formed a fully-owned subsidiary, ERT Asia Group.

The KK registration enables ERT to broaden the local services it provides in Japan and establishes a solid foundation to expand its Asian presence. Along with this registration, ERT will grow the number of local resources in Japan that will work directly with its customers to deploy Japan-based projects.

Having already deployed solutions in over 1,200 studies in Asia, this expansion enhances ERT’s capabilities to support the growing number of biopharmaceutical companies who are utilizing its eClinical solutions in trials throughout Asia. ERT solutions in cardiac safety, respiratory and eClinical Outcome Assessments (eCOA)—including patient, clinician and observer reported outcomes—have been used to capture primary efficacy and safety data for treatments approved by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).

“We are pleased to have collaborated with so many global and domestic biopharmaceutical organizations on their Japanese-based clinical trials and to have delivered the valuable data they need to evaluate their products’ safety and efficacy profiles,” said Robert  Brown, vice president of  business development Asia-Pacific, ERT. “Increasing the number of local ERT resources will enable us to work more collaboratively with our customers and our excellent partners in Japan and other Asian countries to increase efficiencies in study execution and improve the integrity of data collected in clinical research.”

ERT has launched a localized version of its corporate website to help Japanese biopharmaceutical researchers access important information about ERT’s eClinical trial solutions, capabilities and currently available positions. Website visitors can also view and download educational content including recent industry publications, podcasts and webinars on topics pertaining to cardiac safety, respiratory and COA data collection via the site’s comprehensive resource center.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs